Month : October 2023

Merck, a global pharmaceutical giant, has inked a partnership with Japanese firm Daiichi Sankyo, valuing at $5.5 billion, to co-develop three advanced cancer therapies. Depending on the success of these pioneering cell-targeted treatments, the agreement could garner up to $22 billion for Daiichi. This partnership triggered a significant positive response in......

Pharmaceutical giant Pfizer has announced its intention to charge $1,400 for a five-day course of its antiviral drug Paxlovid. This marks a significant increase from the $529 the US government previously paid for the same quantity of the drug during the pandemic. The Wall Street Journal reports that Pfizer communicated the new pricing in......

Solar stocks took a significant hit on Friday as Solaredge, a prominent solar product manufacturer, indicated a sharp decline in European demand. This warning further dampened the sentiment surrounding the renewable energy sector, which has already been grappling with challenges throughout the year. The Invesco Solar ETF (TAN) faced a 6.57% decline on......

After releasing its Q3 financial results, Tesla’s stock took a significant hit, plummeting by nearly 10%. While the Q3 results did not meet market expectations, the stock remained stable initially, possibly buoyed by the much-anticipated Cybertruck delivery event announcement. However, the subsequent conference call with CEO Elon Musk led to a more negative market response. Several......